See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← PER page
XStocksXray
Market X-Ray report · 23 October 2026

Pernod Ricard SA (PER)

XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 67.82
52-week range57.90 – 89.84
Return, 1 month / 3 months+14.3% / +9.8%
Return, 1 year / 3 years−18.3% / −52.9%
TrendUptrend
RSI (14)66
Volatility (1 year)31.0%
Worst drawdown (1 year)-31.2%
Average daily value traded0.20M EUR
Dividend yield6.9%

Market X-Ray price-based

57/ 100 · High confidence · ahead of 58% of stocks on this exchange
Trend50
Momentum54
Stability (higher is calmer)57
Liquidity53
Income91

Five-year price chart navy: price · brown: 200-day average

50.0185.771221571932021-102023-032024-072025-092026-10

About the company

Pernod Ricard is a French drinks company based in Paris that makes and markets spirits and wines. Its range covers anise-based aperitifs such as pastis, whisky brands from Scotland and Ireland, vodka, cognac, gin, rum and champagne, along with still wines. The company sells to distributors, retailers, bars, restaurants and hotels in markets around the world, and its brand portfolio is managed across several regional sales organisations.

Pernod Ricard SA trades under the code PER on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Pernod Ricard SA (PER) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 67.82 on 23 October 2026.

Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 292 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 18.3% and over the last three months it rose 9.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Pernod Ricard SA (PER)

The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange

Lens and metricValueScoreReading
Trend50 · WeakBelow its long-term averages and far from its highs.
Above 200-day average3.7%
From 52-week high-23.5%
Momentum54 · FairTypical recent returns for this exchange.
3-month return9.8%
6-month return7.0%
12-month return, skipping the last month-28.5%
Stability (higher is calmer)57 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)31.0%
Worst drawdown, 1 year (smaller is calmer)-31.2%
Liquidity53 · FairModerate trading activity.
Average daily value traded0.20M EUR
Zero-volume days0.0%
Income91 · StrongDividend is high and has been paid regularly.
Dividend yield6.9%
Years with dividends6

Strengths

  • Income: Dividend is high and has been paid regularly.

Weak spots

  • Trend: Below its long-term averages and far from its highs.

Returns

1 week−0.9%
1 month+14.3%
3 months+9.8%
6 months+7.0%
1 year−18.3%
3 years−52.9%
5 years−58.8%

Signals

50-day / 200-day average63.05 / 65.39
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.46

Technical summary

DailyStrongly bullish12 bullish · 2 neutral · 2 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

Recent dividends

Ex-dividend dateAmount per share
22 Jul 2026EUR 2.3500
24 Nov 2025EUR 2.3500
23 Jul 2025EUR 2.3500
25 Nov 2024EUR 2.3500
17 Jul 2024EUR 2.3500
24 Nov 2023EUR 2.6400

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026